@article{ART002587079,
author={장선희 and 허재영 and 최윤라 and 이창훈 and 김완섭},
title={Current status and future perspectives of liquid biopsy in non-small cell lung cancer},
journal={Journal of Pathology and Translational Medicine},
issn={2383-7837},
year={2020},
volume={54},
number={3},
pages={204-212},
doi={https://doi.org/10.4132/jptm.2020.02.27}
}

TY - JOUR
AU - 장선희
AU - 허재영
AU - 최윤라
AU - 이창훈
AU - 김완섭
TI - Current status and future perspectives of liquid biopsy in non-small cell lung cancer
T2 - Journal of Pathology and Translational Medicine
JO - Journal of Pathology and Translational Medicine
PY - 2020
VL - 54
IS - 3
PB - 대한병리학회
SP - 204
EP - 212
SN - 2383-7837
AB - With advances in target therapy, molecular analysis of tumors is routinely required for treatment decisions in patients with advanced non-small cell lung cancer (NSCLC). Liquid biopsy refers to the sampling and analysis of circulating cell-free tumor DNA (ctDNA) in various body fluids, primarily blood. Because the technique is minimally invasive, liquid biopsies are the future in cancer management. Epidermal growth factor receptor (EGFR) ctDNA tests have been performed in routine clinical practice in advanced NSCLC patients to guide tyrosine kinase inhibitor treatment. In the near future, liquid biopsy will be a crucial prognostic, predictive, and diagnostic method in NSCLC. Here we present the current status and future perspectives of liquid biopsy in NSCLC.
KW - Carcinoma, non-small cell lung cancer, Liquid biopsy, Circulating tumor DNA, Epidermal growth factor receptor, Biomarkers
DO - https://doi.org/10.4132/jptm.2020.02.27
ER -

장선희, 허재영, 최윤라, 이창훈 and 김완섭. 2020, "Current status and future perspectives of liquid biopsy in non-small cell lung cancer", Journal of Pathology and Translational Medicine, vol.54, no.3 pp.204-212. Available from: doi:https://doi.org/10.4132/jptm.2020.02.27

장선희, 허재영, 최윤라, 이창훈, 김완섭 "Current status and future perspectives of liquid biopsy in non-small cell lung cancer" Journal of Pathology and Translational Medicine 54.3 pp.204-212 (2020) : 204.

장선희, 허재영, 최윤라, 이창훈, 김완섭. Current status and future perspectives of liquid biopsy in non-small cell lung cancer. 2020; 54(3), 204-212. Available from: doi:https://doi.org/10.4132/jptm.2020.02.27

장선희, 허재영, 최윤라, 이창훈 and 김완섭. "Current status and future perspectives of liquid biopsy in non-small cell lung cancer" Journal of Pathology and Translational Medicine 54, no.3 (2020) : 204-212.doi: https://doi.org/10.4132/jptm.2020.02.27

장선희; 허재영; 최윤라; 이창훈; 김완섭. Current status and future perspectives of liquid biopsy in non-small cell lung cancer. Journal of Pathology and Translational Medicine, 54(3), 204-212. doi: https://doi.org/10.4132/jptm.2020.02.27

장선희; 허재영; 최윤라; 이창훈; 김완섭. Current status and future perspectives of liquid biopsy in non-small cell lung cancer. Journal of Pathology and Translational Medicine. 2020; 54(3) 204-212. doi: https://doi.org/10.4132/jptm.2020.02.27

장선희, 허재영, 최윤라, 이창훈, 김완섭. Current status and future perspectives of liquid biopsy in non-small cell lung cancer. 2020; 54(3), 204-212. Available from: doi:https://doi.org/10.4132/jptm.2020.02.27

장선희, 허재영, 최윤라, 이창훈 and 김완섭. "Current status and future perspectives of liquid biopsy in non-small cell lung cancer" Journal of Pathology and Translational Medicine 54, no.3 (2020) : 204-212.doi: https://doi.org/10.4132/jptm.2020.02.27